MARTIN DREYLING,DANIEL ALEXANDER HEINRICH,FRANK HERTING,CHRISTIAN KLEIN
申请号：
US13745652
公开号：
US20140010804A1
申请日:
2013.01.18
申请国别(地区):
US
年份:
2014
代理人:
摘要：
The present invention is directed to the combination therapy of an afucosylated anti-CD20 antibody with fludarabine and/or mitoxantrone for the treatment of cancer, especially to the combination therapy of CD20 expressing cancers with an afucosylated humanized B-Ly1 antibody with fludarabine and/or mitoxantrone.
